Business Wire

AKUR8

8.2.2022 14:02:07 CET | Business Wire | Press release

Share
HDI Seguros Chooses Akur8 to Strengthen Its Pricing Process in Chile

HDI Seguros and Akur8 announced a collaboration to enhance HDI’s pricing process in Chile. This deal reinforces the presence of Akur8 in Latin America and marks its entry into the Chilean insurance market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220208005001/en/

Through Transparent Artificial Intelligence Technology, Akur8’s cloud-based solution boosts insurance companies’ pricing capabilities by automating risk modelling. This way, insurers obtain major benefits including improved predictive performance, and speed-to-accuracy for greater market responsiveness and immediate business impact, while maintaining full transparency and control over the models created.

“This alliance with Akur8 is another proof point of our tech and digital DNA. Embracing best-in-class technology to ensure faster, more accurate and fully transparent rate making is a key differentiator and HDI Seguros is excited to lead the way”, commented Felipe Feres, General Manager at HDI Seguros in Chile.

Part of the global multi-brand Talanx Group, active in financial and insurance services in more than 150 countries, HDI Seguros is a pioneer company in the insurance business in Chile, known and recognized for their quality of service and innovative products leveraging new technologies. HDI Seguros will leverage Akur8’s Risk and Demand modules for its P&C personal and commercial lines. With Akur8, HDI Seguros will enhance its modelling accuracy and further accelerate its market responsiveness, leading the way in terms of best-in-class pricing in the insurance space.

“We are proud to announce our collaboration with HDI Seguros in Chile, pioneer in the Insurance business pricing digitalization and sophistication. Akur8 is proud to be the pricing platform chosen by HDI Seguros and to bring revolutionary speed and performance to their pricing teams, as well as keeping the complete auditability of the process, stated Samuel Falmagne, CEO at Akur8.

“Entering the Chilean market is wonderful news. We have a strong Spanish-speaking team addressing the Latin American market and we are delighted to strengthen our presence there. Building this new collaboration with HDI Seguros is a tremendous step forward, it demonstrates once more the attractiveness of Akur8’s solution across the globe”, stated Brune de Linares, Chief of Sales at Akur8.

“Our pricing teams are looking forward to leveraging Akur8 every day after the results of the pilot project which allowed them to fully measure the power of the Akur8 platform. Akur8 will empower them in their efforts to improve our rate making process, build new capabilities and deliver increased business value for HDI Seguros” , added Camilo Torres Valenzuela, Pricing Ass. Manager at HDI Seguros in Chile.

About Akur8

Akur8 is revolutionizing insurance pricing with transparent AI. Akur8 developed a unique AI-based insurance pricing solution that automates modelling for insurance companies while keeping full transparency and control on the models created, as required by regulators worldwide. Akur8 is the only solution on the market reconciling Machine Learning and Actuarial worlds.

About HDI Seguros - Chile

HDI Seguros is one of the most important insurance companies of Chile, known for providing excellence in customer service, keeping an innovative offer of products and services and a proposal of value which integrates the digitalization of products and processes, the interchange of best practices and development of new technologies. It is part of the Talanx Group, the third major insurance holdings in Germany, seventh in Europe and also controller of Hannover RE, one of the leading reinsurance companies worldwide.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye